Literature DB >> 24130223

Characterizing the temporal dynamics of human papillomavirus DNA detectability using short-interval sampling.

Su-Hsun Liu1, Derek A T Cummings, Jonathan M Zenilman, Patti E Gravitt, Rebecca M Brotman.   

Abstract

BACKGROUND: Variable detection of human papillomavirus (HPV) DNA can result in misclassification of infection status, but the extent of misclassification has not been quantitatively evaluated.
METHODS: In 2005-2007, 33 women of ages 22 to 53 years self-collected vaginal swabs twice per week for 16 consecutive weeks. Each of the 955 swabs collected was tested for 37 HPV types/subtypes. Assuming that a woman's underlying infection status did not change over the short study period, biases in prevalence estimates obtained from single versus multiple swabs were calculated. Using event history analysis methods, time to recurrent gain and loss of at least one HPV type was determined, separately. Baseline any-type and high risk-type HPV prevalence was 60.6% and 24.2%, respectively. Cumulative any-HPV and high-risk HPV prevalence over the 16-week period was 84.8% and 60.6%, separately.
RESULTS: Overall, there were 319 events of detection and 313 events of loss of detection. Median times to a recurrent detection and loss of detection were 11 and seven days, respectively. Neither vaginal sex nor condom use during follow-up was associated with recurrent viral detection or loss of detection. Assuming the cumulative 16-week prevalence reflects the true prevalence of infection, the baseline any-HPV prevalence underestimated infection status by 24.2%, with a bootstrapped mean of 20.2% [95% confidence interval (CI), 8.9%-29.6%].
CONCLUSIONS: These findings suggest that a substantial proportion of HPV-infected women are misclassified as being uninfected when using a single-time DNA measurement. IMPACT: Short-term variation in detectable HPV DNA needs to be considered while interpreting the natural history of infections using single samples collected at long intervals.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24130223      PMCID: PMC3947138          DOI: 10.1158/1055-9965.EPI-13-0666

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  27 in total

Review 1.  A critique of cohort studies examining the role of human papillomavirus infection in cervical neoplasia.

Authors:  Ciaran B J Woodman; Stuart Collins
Journal:  BJOG       Date:  2002-12       Impact factor: 6.531

2.  Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype.

Authors:  Cornelia L Trimble; Steven Piantadosi; Patti Gravitt; Brigitte Ronnett; Ellen Pizer; Andrea Elko; Barbara Wilgus; William Yutzy; Richard Daniel; Keerti Shah; Shiwen Peng; Chienfu Hung; Richard Roden; Tzyy Choou Wu; Drew Pardoll
Journal:  Clin Cancer Res       Date:  2005-07-01       Impact factor: 12.531

3.  Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis.

Authors:  G S Ogilvie; D M Patrick; M Schulzer; J W Sellors; M Petric; K Chambers; R White; J M FitzGerald
Journal:  Sex Transm Infect       Date:  2005-06       Impact factor: 3.519

4.  Menstrual cycle and detectable human papillomavirus in reproductive-age women: a time series study.

Authors:  Su-Hsun Liu; Rebecca M Brotman; Jonathan M Zenilman; Patti E Gravitt; Derek A T Cummings
Journal:  J Infect Dis       Date:  2013-07-24       Impact factor: 5.226

Review 5.  The natural history of cervical HPV infection: unresolved issues.

Authors:  Ciaran B J Woodman; Stuart I Collins; Lawrence S Young
Journal:  Nat Rev Cancer       Date:  2007-01       Impact factor: 60.716

6.  A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women.

Authors:  Darron R Brown; Marcia L Shew; Brahim Qadadri; Nicole Neptune; Maria Vargas; Wanzhu Tu; Beth E Juliar; Timothy E Breen; J Dennis Fortenberry
Journal:  J Infect Dis       Date:  2004-12-10       Impact factor: 5.226

7.  The effect of vaginal douching cessation on bacterial vaginosis: a pilot study.

Authors:  Rebecca M Brotman; Khalil G Ghanem; Mark A Klebanoff; Taha E Taha; Daniel O Scharfstein; Jonathan M Zenilman
Journal:  Am J Obstet Gynecol       Date:  2008-03-04       Impact factor: 8.661

8.  Persistence of genital human papillomavirus infection in a long-term follow-up study of female university students.

Authors:  Laura K Sycuro; Long Fu Xi; James P Hughes; Qinghua Feng; Rachel L Winer; Shu-Kuang Lee; Sandra O'Reilly; Nancy B Kiviat; Laura A Koutsky
Journal:  J Infect Dis       Date:  2008-10-01       Impact factor: 5.226

9.  Variability of human papillomavirus DNA testing in a longitudinal cohort of young women.

Authors:  A B Moscicki; J Palefsky; G Smith; S Siboshski; G Schoolnik
Journal:  Obstet Gynecol       Date:  1993-10       Impact factor: 7.661

10.  Human papillomavirus DNA in women without and with cytological abnormalities: results of a 5-year follow-up study.

Authors:  E M de Villiers; D Wagner; A Schneider; H Wesch; F Munz; H Miklaw; H zur Hausen
Journal:  Gynecol Oncol       Date:  1992-01       Impact factor: 5.482

View more
  18 in total

1.  Importance of Lifetime Sexual History on the Prevalence of Genital Human Papillomavirus (HPV) Among Unvaccinated Adults in the National Health and Nutrition Examination Surveys: Implications for Adult HPV Vaccination.

Authors:  Anne F Rositch; Eshan U Patel; Molly R Petersen; Thomas C Quinn; Patti E Gravitt; Aaron A R Tobian
Journal:  Clin Infect Dis       Date:  2021-05-04       Impact factor: 9.079

2.  Tracking vaginal, anal and oral infection in a mouse papillomavirus infection model.

Authors:  Jiafen Hu; Lynn R Budgeon; Nancy M Cladel; Karla Balogh; Roland Myers; Timothy K Cooper; Neil D Christensen
Journal:  J Gen Virol       Date:  2015-12       Impact factor: 3.891

Review 3.  Role of the microbiome in non-gastrointestinal cancers.

Authors:  Meirav Pevsner-Fischer; Timur Tuganbaev; Mariska Meijer; Sheng-Hong Zhang; Zhi-Rong Zeng; Min-Hu Chen; Eran Elinav
Journal:  World J Clin Oncol       Date:  2016-04-10

4.  Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection.

Authors:  Rebecca M Brotman; Michelle D Shardell; Pawel Gajer; J Kathleen Tracy; Jonathan M Zenilman; Jacques Ravel; Patti E Gravitt
Journal:  J Infect Dis       Date:  2014-06-18       Impact factor: 5.226

5.  Prevalent high-risk HPV infection and vaginal microbiota in Nigerian women.

Authors:  E O Dareng; B Ma; A O Famooto; S N Adebamowo; R A Offiong; O Olaniyan; P S Dakum; C M Wheeler; D Fadrosh; H Yang; P Gajer; R M Brotman; J Ravel; C A Adebamowo
Journal:  Epidemiol Infect       Date:  2015-06-11       Impact factor: 4.434

Review 6.  The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next?

Authors:  Anita Mitra; David A MacIntyre; Julian R Marchesi; Yun S Lee; Phillip R Bennett; Maria Kyrgiou
Journal:  Microbiome       Date:  2016-11-01       Impact factor: 14.650

Review 7.  Natural History of HPV Infection across the Lifespan: Role of Viral Latency.

Authors:  Patti E Gravitt; Rachel L Winer
Journal:  Viruses       Date:  2017-09-21       Impact factor: 5.048

8.  HPV clearance and the neglected role of stochasticity.

Authors:  Marc D Ryser; Evan R Myers; Rick Durrett
Journal:  PLoS Comput Biol       Date:  2015-03-13       Impact factor: 4.475

Review 9.  Why Human Papillomavirus Acute Infections Matter.

Authors:  Samuel Alizon; Carmen Lía Murall; Ignacio G Bravo
Journal:  Viruses       Date:  2017-10-10       Impact factor: 5.048

10.  Rates of New Human Papillomavirus Detection and Loss of Detection in Middle-aged Women by Recent and Past Sexual Behavior.

Authors:  Proma Paul; Anne Hammer; Anne F Rositch; Anne E Burke; Raphael P Viscidi; Michelle I Silver; Nicole Campos; Ada O Youk; Patti E Gravitt
Journal:  J Infect Dis       Date:  2021-04-23       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.